Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
ALAlbireo Pharma, Inc. logo

Albireo Pharma, Inc. (ALBO)

NASDAQ Capital Market · Currency in USD
$44.15 ▲ +0.00 (+0.00%)
At close: Mar 2, 4:00 PM ET. Market closed.

Summary

Previous Close
$44.15
Open
$44.90
Day's Range
$44.00 – $44.90
52 Week Range
$16.02 – $45.23
Volume
1,236,106
Avg. Volume
591,257
Market Cap
$915.89M
Beta (5Y Monthly)
1.04
PE Ratio (TTM)
--
EPS (TTM)
-$7.87
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$44.00

Profile: Albireo Pharma, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
130
CEO
Ronald H. W. Cooper
Website
ipsen.com

Albireo Pharma, Inc. is a biopharmaceutical company with marketed products, dedicated to researching, developing, and commercializing new treatments that modify bile acids. The company primarily targets rare liver diseases in children, as well as various other conditions affecting the liver or digestive system. Its portfolio includes Bylvay, a treatment approved for progressive familial intrahepatic cholestasis.

Earnings

DateEst.Actual
Mar 7, 2023-$1.80-$0.57Beat
Nov 8, 2022-$1.06-$1.92Miss
Aug 15, 2022-$1.65-$2.04Miss
May 16, 2022-$1.85-$2.19Miss
Mar 1, 2022-$1.35-$0.57Beat
Nov 4, 2021-$0.38$2.90Beat

Analyst view

Consensus price target
$44.00 ▼ -0.3%
Range $42.00 – $48.00
Rating: Buy
Buy 58% · Hold 42% · Sell -0%

Get free alerts on ALBO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.